Prophylactic lithium in affective disorders. Controlled trial.
D000284:Administration, Oral; D000328:Adult; D000342:Affective Symptoms / Q000517:prevention & control*; D000368:Aged; D000704:Analysis of Variance; D000928:Antidepressive Agents / Q000627:therapeutic use; D002254:Carbonates / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D004565:Electroconvulsive Therapy; D005260:Female; D006760:Hospitalization; D006778:Hospitals, Psychiatric; D006801:Humans; D007902:Length of Stay; D008094:Lithium / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012008:Recurrence; D013997:Time Factors
D000928:Antidepressive Agents; D002254:Carbonates; D010919:Placebos; D008094:Lithium